Call for Collaborating Partners for National Women's Health Week, 2545-2546 [2010-757]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 10 / Friday, January 15, 2010 / Notices
bank holding companies may be
obtained from the National Information
Center website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than January 29, 2010.
A. Federal Reserve Bank of Dallas (E.
Ann Worthy, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. One World Holdings, Inc., Dallas,
Texas; to engage de novo through its
subsidiary, One World Asset
Management, Inc., Dallas, Texas, in
lending activities, pursuant to section
225.28(b)(1) of Regulation Y.
Board of Governors of the Federal Reserve
System, January 11, 2010.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2010–602 Filed 1–14–10; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Toxicology Program (NTP);
Center for the Evaluation of Risks to
Human Reproduction (CERHR);
Availability of the Final Expert Panel
Report on Soy Infant Formula; Request
for Public Comment
jlentini on DSKJ8SOYB1PROD with NOTICES
AGENCY: National Institute of
Environmental Health Sciences
(NIEHS); National Institutes of Health
(NIH); HHS.
ACTION: Announcement of report
availability and request for comment.
SUMMARY: CERHR announces the
availability of the final expert panel
report on soy infant formula on January
15, 2010, from the CERHR Web site
(https://cerhr.niehs.nih.gov) or in
hardcopy from CERHR (see ADDRESSES
below). The expert panel report is an
evaluation of the developmental toxicity
of soy infant formula conducted by an
independent, 14-member expert panel
composed of scientists from the public
and private sectors convened by
CERHR. CERHR invites the submission
of public comments on this report (see
SUPPLEMENTARY INFORMATION below).
The expert panel met in public session
(December 16–18, 2009) to review and
revise the draft expert panel report and
reach conclusions regarding whether
exposure to soy infant formula is a
hazard to human development. The
expert panel also identified data gaps
and research needs.
VerDate Nov<24>2008
17:34 Jan 14, 2010
Jkt 220001
DATES: The final expert panel report on
soy infant formula will be available for
public comment on January 15, 2010.
Written public comments on this report
should be received by March 1, 2010.
Comments on the expert
panel report and any other
correspondence should be submitted to
Dr. Kristina A. Thayer, Acting CERHR
Director, NIEHS, P.O. Box 12233, MD
K2–04, Research Triangle Park, NC
27709 (mail), 919–541–5021
(telephone), or thayer@niehs.nih.gov (email). Courier address: NIEHS, 530
Davis Drive, Room K2154, Morrisville,
NC 27560.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
Background
Soy infant formula is fed to infants as
a supplement or replacement for human
milk or cow milk formula. Soy infant
formula contains isoflavones such as
genistein (CAS RN: 446–72–0), daidzein
(CAS RN: 486–66–8), and glycitein (CAS
RN: 40957–83–3). Genistein, daidzein,
glycitein, and the daidzein metabolite
equol are non-steroidal, estrogenic
compounds that occur naturally in some
plants and are often referred to as
‘‘phytoestrogens.’’ In plants, nearly all
genistein, daidzein, and glycitein are
linked to a sugar molecule and these
isoflavone-sugar complexes are called
genistin, daidzin, or glycitin.
On December 16–18, 2009, CERHR
(74 FR 53508) convened an expert panel
to conduct an updated evaluation of the
potential developmental toxicity of soy
infant formula and its predominant
isoflavone constituents. CERHR selected
soy infant formula for evaluation
because of (1) The availability of
numerous developmental toxicity
studies in laboratory animals and
humans, (2) the availability of
information on exposures in infants,
and (3) public concern for effects on
infant or child development.
Following receipt of public comments
on the final expert panel report on soy
infant formula, CERHR staff will prepare
the NTP monograph. NTP monographs
are divided into three major sections: (1)
The NTP Brief that provides the NTP’s
interpretation of the potential for the
substance to cause adverse reproductive
and/or developmental effects in exposed
humans, (2) a roster of expert panel
members, and (3) the final expert panel
report. The NTP Brief is based on the
expert panel report, public comments
on that report, public and peer review
comments on the draft NTP Brief, and
any new, relevant information that
becomes available after the expert panel
meetings.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
2545
Request for Comments
CERHR invites written public
comments on the expert panel report on
soy infant formula. Written comments
should be sent to Dr. Kristina A. Thayer
(see ADDRESSES above). Persons
submitting written comments are asked
to include their name and contact
information (affiliation, mailing address,
telephone and facsimile numbers, email, and sponsoring organization, if
any). Any comments received will be
posted on the CERHR Web site and the
commenter identified by name,
affiliation, and sponsoring organization,
if applicable. All public comments will
be considered by the NTP during
preparation of the NTP Brief (see
‘‘Background’’ above).
Background Information on CERHR
The NTP established CERHR in 1998
(63 FR 68782). CERHR is a publicly
accessible resource for information
about adverse reproductive and/or
developmental health effects associated
with exposure to environmental and/or
occupational exposures. CERHR follows
a formal process for the evaluation of
selected substances that includes
multiple opportunities for public input.
CERHR invites the nomination of
substances for review or scientists for its
expert registry. Information about
CERHR and the nomination process can
be obtained from its homepage (https://
cerhr.niehs.nih.gov) or by contacting Dr.
Thayer (see ADDRESSES above). CERHR
selects substances for evaluation based
upon several factors including
production volume, potential for human
exposure from use and occurrence in
the environment, extent of public
concern, and extent of data from
reproductive and developmental
toxicity studies.
Dated: January 8, 2010.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2010–674 Filed 1–14–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Call for Collaborating Partners for
National Women’s Health Week
AGENCY: Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science,
Office on Women’s Health.
ACTION: Notice.
SUMMARY: The U.S. Department of
Health and Human Services (HHS),
Office on Women’s Health (OWH)
E:\FR\FM\15JAN1.SGM
15JAN1
2546
Federal Register / Vol. 75, No. 10 / Friday, January 15, 2010 / Notices
invites public and private sector
women’s health-related organizations to
participate in National Women’s Health
Week as collaborating partners to help
create awareness of women’s health
issues and educate women about
improving their health and preventing
disease.
DATES: Representatives of women’s
health organizations should submit
expressions of interest by February 28,
2010.
Expressions of interest,
comments, and questions may be
submitted by electronic mail to
Henrietta.Terry@hhs.gov or by regular
mail to Henrietta Terry, M.S., Public
Health Advisor, Office on Women’s
Health, Department of Health and
Human Services, 200 Independence
Avenue, SW., Room 733E, Washington,
DC 20201; or via fax to (202–690–7172).
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Henrietta Terry, M.S., Public Health
Advisor, Office on Women’s Health,
Department of Health and Human
Services, 200 Independence Avenue,
SW., Room 733E, Washington, DC
20201, (202) 205–1952 (telephone), or
(202) 690–7172 (fax).
The OWH
was established in 1991 to improve the
health of American women by
advancing and coordinating a
comprehensive women’s health agenda
throughout HHS. This program has two
goals: Development and implementation
of model programs on women’s health;
and leading education, collaboration,
and coordination on women’s health.
The program fulfills its mission through
competitive contracts and grants to an
array of community, academic, and
other organizations at the national and
community levels. National educational
campaigns provide information about
the important steps women can take to
improve and maintain their health, such
as National Women’s Health Week.
National Women’s Health Week is a
week long health observance that kicks
off on Mother’s Day and seeks to
educate women about improving their
physical and mental health and
preventing disease. With the 2010
theme ‘‘It’s Your Time,’’ OWH will focus
on encouraging women to make their
health a top priority and take simple
steps for a longer, healthier and happier
life. For more information about
National Women’s Health Week, please
visit https://www.womenshealth.gov/
whw.
jlentini on DSKJ8SOYB1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Nov<24>2008
17:34 Jan 14, 2010
Jkt 220001
Dated: January 7, 2010.
Frances Ashe-Goins,
Acting Director, Office on Women’s Health.
[FR Doc. 2010–757 Filed 1–14–10; 8:45 am]
BILLING CODE 4150–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
AGENCY: Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science.
ACTION: Notice.
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service (DHHS) is hereby giving notice
that the Presidential Advisory Council
on HIV/AIDS (PACHA) will hold a
meeting. The meeting will be open to
the public.
DATES: The meeting will be held on
February 2, 2010 from 9 a.m. to
approximately 5 p.m.
ADDRESSES: South Court Auditorium,
Eisenhower Executive Office Building,
Pennsylvania Avenue and 17th Street,
NW., Washington, DC 20501.
FOR FURTHER INFORMATION CONTACT: Mr.
Melvin Joppy, Committee Manager,
Presidential Advisory Council on HIV/
AIDS, Department of Health and Human
Services, 200 Independence Avenue,
SW., Room 443H, Hubert H. Humphrey
Building, Washington, DC 20201; (202)
690–5560. More detailed information
about PACHA can be obtained by
accessing the Council’s Web site at
https://www.pacha.gov.
SUPPLEMENTARY INFORMATION: PACHA
was established by Executive Order
12963, dated June 14, 1995 as amended
by Executive Order 13009, dated June
14, 1996. The Council was established
to provide advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to (a) Promote effective
prevention of HIV disease, (b) advance
research on HIV and AIDS, and (c)
promote quality services to persons
living with HIV disease and AIDS.
PACHA was established to serve solely
as an advisory body to the Secretary of
Health and Human Services.
The agenda for this Council meeting
will be posted on the Council’s Web site
https://www.pacha.gov.
This meeting of the PACHA will be on
White House property, thus, each
person must be screened and cleared by
the U.S. Secret Service. Pre-registration
for public attendance is mandatory.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Please contact: Natalie Pojman, Office of
National AIDS Policy (202) 456–4533 or
npojman@who.eop.gov. Members of the
public will be accommodated on a first
come first served basis as meeting room
space is limited. Ms. Pojman will need
your full name, social security number,
date of birth, residency and country of
origin to process public access
attendance. Pre-registration must be
submitted by close of business January
28, 2010.
Members of the public will have the
opportunity to provide comments at the
meeting. Any individual who wishes to
participate in the public comment
session must register at https://
www.pacha.gov; registration for public
comment will not be accepted by
telephone. Public comment will be
limited to two minutes per speaker. Any
members of the public who wish to have
printed material distributed to PACHA
members for discussion at the meeting
should submit, at a minimum, 30 copies
of the materials to the Committee
Manager, PACHA, no later than close of
business January 29, 2010. Contact
information for the PACHA Committee
Manager is listed above.
Dated: January 12, 2010.
Christopher Bates,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. 2010–744 Filed 1–14–10; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Opportunity for Co-Sponsorship of the
President’s Challenge Physical Activity
and Fitness Awards Program;
Correction
AGENCY: President’s Council on Physical
Fitness and Sports.
ACTION: Notice; correction.
SUMMARY: The President’s Council on
Physical Fitness and Sports published a
document in the Federal Register of
December 28, 2009, concerning the
opportunity for non-Federal entities to
co-sponsor and administer a series of
financially self-sustaining activities
related to the President’s Challenge
Physical Activity and Fitness Awards
Program. The document contained
incorrect addresses and contact
information.
FOR FURTHER INFORMATION CONTACT: Jane
Wargo, 202.690.5157
Correction
In the Federal Register of December
28, 2009, in FR Doc. E9–30653, on page
68626, in the third column, correct the
E:\FR\FM\15JAN1.SGM
15JAN1
]]>Agencies
[Federal Register Volume 75, Number 10 (Friday, January 15, 2010)]
[Notices]
[Pages 2545-2546]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-757]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Call for Collaborating Partners for National Women's Health Week
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of Public Health and Science, Office on Women's
Health.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services (HHS), Office
on Women's Health (OWH)
[[Page 2546]]
invites public and private sector women's health-related organizations
to participate in National Women's Health Week as collaborating
partners to help create awareness of women's health issues and educate
women about improving their health and preventing disease.
DATES: Representatives of women's health organizations should submit
expressions of interest by February 28, 2010.
ADDRESSES: Expressions of interest, comments, and questions may be
submitted by electronic mail to Henrietta.Terry@hhs.gov or by regular
mail to Henrietta Terry, M.S., Public Health Advisor, Office on Women's
Health, Department of Health and Human Services, 200 Independence
Avenue, SW., Room 733E, Washington, DC 20201; or via fax to (202-690-
7172).
FOR FURTHER INFORMATION CONTACT: Henrietta Terry, M.S., Public Health
Advisor, Office on Women's Health, Department of Health and Human
Services, 200 Independence Avenue, SW., Room 733E, Washington, DC
20201, (202) 205-1952 (telephone), or (202) 690-7172 (fax).
SUPPLEMENTARY INFORMATION: The OWH was established in 1991 to improve
the health of American women by advancing and coordinating a
comprehensive women's health agenda throughout HHS. This program has
two goals: Development and implementation of model programs on women's
health; and leading education, collaboration, and coordination on
women's health. The program fulfills its mission through competitive
contracts and grants to an array of community, academic, and other
organizations at the national and community levels. National
educational campaigns provide information about the important steps
women can take to improve and maintain their health, such as National
Women's Health Week.
National Women's Health Week is a week long health observance that
kicks off on Mother's Day and seeks to educate women about improving
their physical and mental health and preventing disease. With the 2010
theme ``It's Your Time,'' OWH will focus on encouraging women to make
their health a top priority and take simple steps for a longer,
healthier and happier life. For more information about National Women's
Health Week, please visit https://www.womenshealth.gov/whw.
Dated: January 7, 2010.
Frances Ashe-Goins,
Acting Director, Office on Women's Health.
[FR Doc. 2010-757 Filed 1-14-10; 8:45 am]
BILLING CODE 4150-33-P
